Restaging breast cancer after somatostatin receptor scintigraphy with [In-111-DTPA-Phe-1]-octreotide

被引:0
|
作者
Giannakenas, C
Tzorakoleftherakis, E
Kalofonos, HP
Petsas, T
Vassilakos, PJ
机构
[1] UNIV PATRAS,REG HOSP,DEPT NUCL MED,PATRAS,GREECE
[2] UNIV PATRAS,REG HOSP,DEPT SURG,PATRAS,GREECE
[3] UNIV PATRAS,REG HOSP,DEPT ONCOL,PATRAS,GREECE
[4] UNIV PATRAS,REG HOSP,DEPT RADIOL,PATRAS,GREECE
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:219 / 219
页数:1
相关论文
共 50 条
  • [1] Scintigraphic detection of SCLC with a radiolabeled somatostatin analogue [in-111-DTPA-Phe-1]-octreotide
    Giannakenas, C
    Kalofonos, HP
    Apostolopoulos, D
    Chondromaras, A
    Yarmenitis, SD
    Petsas, T
    VAssilakos, PJ
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 169 - 172
  • [2] LOCALIZATION OF METASTATIC GASTROENTEROPANCREATIC TUMORS BY SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE
    HAMMOND, PJ
    ARKA, A
    PETERS, AM
    BLOOM, SR
    GILBEY, SG
    QUARTERLY JOURNAL OF MEDICINE, 1994, 87 (02): : 83 - 88
  • [3] SOMATOSTATIN RECEPTOR SCINTIGRAPHY OF CARCINOID-TUMORS USING THE [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE
    WESTLIN, JE
    JANSON, ET
    ARNBERG, H
    AHLSTROM, H
    OBERG, K
    NILSSON, S
    ACTA ONCOLOGICA, 1993, 32 (7-8) : 783 - 786
  • [4] 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors
    Forssell-Aronsson, EB
    Nilsson, O
    Benjegård, SA
    Kölby, LK
    Bernhardt, P
    Mölne, J
    Hashemi, SH
    Wängberg, B
    Tisell, LE
    Ahlman, H
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (04) : 636 - 642
  • [5] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH INDIUM-111-DTPA-D-PHE-1-OCTREOTIDE IN MAN - METABOLISM, DOSIMETRY AND COMPARISON WITH IODINE-123-TYR-3-OCTREOTIDE
    KRENNING, EP
    BAKKER, WH
    KOOIJ, PPM
    BREEMAN, WAP
    OEI, HY
    DEJONG, M
    REUBI, JC
    VISSER, TJ
    BRUNS, C
    KWEKKEBOOM, DJ
    REIJS, AEM
    VANHAGEN, PM
    KOPER, JW
    LAMBERTS, SWJ
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (05) : 652 - 658
  • [6] The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment
    Shi, W
    Buchanan, KD
    Johnston, CF
    Larkin, C
    Ong, YL
    Ferguson, R
    Laird, J
    CLINICAL ENDOCRINOLOGY, 1998, 48 (03) : 303 - 309
  • [7] A NEW RADIOLABELED SOMATOSTATIN ANALOG [IN-111-DTPA-D-PHE(1)]RC-160 - PREPARATION, BIOLOGICAL-ACTIVITY, RECEPTOR SCINTIGRAPHY IN RATS AND COMPARISON WITH [IN-111-DTPA-D-PHE(1)]OCTREOTIDE
    BREEMAN, WAP
    HOFLAND, LJ
    VANDERPLUIJM, M
    VANKOETSVELD, PM
    DEJONG, M
    SETYONOHAN, B
    BAKKER, WH
    KWEKKEBOOM, DJ
    VISSER, TJ
    LAMBERTS, SWJ
    KRENNING, EP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (04): : 328 - 335
  • [8] RADIOTHERAPY WITH A RADIOLABELED SOMATOSTATIN ANALOG, [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE
    KRENNING, EP
    KOOIJ, PPM
    BAKKER, WH
    BREEMAN, WAP
    POSTEMA, PTE
    KWEKKEBOOM, DJ
    OEI, HY
    DEJONG, M
    VISSER, TJ
    REIJS, AEM
    LAMBERTS, SWJ
    MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 : 496 - 506
  • [9] (111Indium-DTPA-D-Phe) octreotide scintigraphy in the diagnostic assessment of palpable breast lumps
    Parker, SJ
    Barker, CPG
    McLeod, MA
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S74 - S74
  • [10] Distribution and elimination characteristics of111In-DTPA-D-Phe1-octreotide and111In-DTPA-L-Phe1-octreotide in rats
    Alice Laznickova
    M. Laznicek
    F. Trejtnar
    L. Melicharova
    Kazuko Horuichi Suzuki
    Hiromichi Akizawa
    Yasushi Arano
    Akira Yokoyama
    European Journal of Drug Metabolism and Pharmacokinetics, 2002, 27 : 37 - 43